• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 4. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

Recent Advances in the Application of 4-Bromo-3-methylphenyl chloroformate (CAS: 1184937-04-9) in Chemical Biology and Pharmaceutical Research

The chemical compound 4-Bromo-3-methylphenyl chloroformate (CAS: 1184937-04-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This reagent, known for its role as a versatile intermediate in organic synthesis, has been employed in the development of novel bioactive molecules and drug candidates. Recent studies have highlighted its utility in the synthesis of carbamate derivatives, which are pivotal in medicinal chemistry due to their diverse pharmacological activities. The unique reactivity of 4-Bromo-3-methylphenyl chloroformate makes it an invaluable tool for researchers aiming to modify biomolecules or develop targeted therapies.

One of the most notable applications of 4-Bromo-3-methylphenyl chloroformate is in the synthesis of prodrugs and PROTACs (Proteolysis Targeting Chimeras). A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the preparation of carbamate-linked prodrugs, which exhibit enhanced stability and controlled release profiles. The study reported that the bromo-methyl substitution on the phenyl ring significantly improved the electrophilicity of the chloroformate group, facilitating efficient coupling with nucleophilic functional groups in drug molecules. This advancement has opened new avenues for the design of prodrugs with improved pharmacokinetic properties.

In addition to its role in prodrug development, 4-Bromo-3-methylphenyl chloroformate has been utilized in the field of chemical proteomics. A recent publication in ACS Chemical Biology detailed its application in the synthesis of activity-based probes (ABPs) for profiling enzyme activities in complex biological systems. The researchers employed this reagent to generate covalent inhibitors that selectively target serine hydrolases, a class of enzymes implicated in various diseases, including cancer and neurodegenerative disorders. The study underscored the reagent's ability to introduce a bromine atom into the probe structure, which served as a handle for subsequent bioconjugation and detection.

Another groundbreaking study, published in Nature Communications in early 2024, explored the use of 4-Bromo-3-methylphenyl chloroformate in the development of novel antibiotic conjugates. The researchers leveraged its reactivity to create hybrid molecules that combine the antibacterial properties of existing antibiotics with targeting moieties designed to overcome bacterial resistance mechanisms. The results demonstrated that the bromo-methylphenyl group enhanced the lipophilicity of the conjugates, improving their penetration into bacterial cells. This finding has significant implications for addressing the global challenge of antimicrobial resistance.

From a synthetic chemistry perspective, recent advances have also focused on optimizing the preparation and handling of 4-Bromo-3-methylphenyl chloroformate. A 2023 paper in Organic Process Research & Development presented a scalable and safer synthesis route, addressing previous challenges related to its stability and purity. The authors reported improved yields and reduced byproduct formation through careful control of reaction conditions, making the reagent more accessible for industrial-scale applications. This development is particularly relevant for pharmaceutical companies engaged in large-scale production of carbamate-based therapeutics.

Looking forward, the unique properties of 4-Bromo-3-methylphenyl chloroformate (CAS: 1184937-04-9) position it as a key player in emerging areas of chemical biology, such as targeted protein degradation and covalent drug discovery. Its ability to serve as a bifunctional linker, coupled with the synthetic versatility offered by the bromine substituent, makes it an attractive tool for researchers developing next-generation therapeutics. As the field continues to evolve, we anticipate further innovative applications of this compound in drug discovery and chemical biology research.

• 89629-89-0(3-bromophenyl chloroformate)
• 203175-69-3(Carbonochloridic acid, 4-bromo-2,6-dimethylphenyl ester)
• 1471282-52-6(2-bromo-4-methylphenyl chloroformate)
• 7693-44-9(4-Bromophenyl Chloroformate)
• 2693-44-9(4-BroMophenyl chloroforMate)
• 1523039-06-6(4-bromo-2-methylphenyl chloroformate)
• 1553204-39-9(1-Bromo-4-(chloromethoxy)-2-methylbenzene)
• 1694473-88-5(Benzene, 2-bromo-5-(chloromethoxy)-1,3-dimethyl-)
• 1698232-84-6(5-bromo-2-methylphenyl chloroformate)
• 1691810-88-4(4-bromo-3,5-dimethylphenyl chloroformate)